News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Loretta Fiorillo, MD, FRCPC

Articles by Loretta Fiorillo, MD, FRCPC

Apremilast Demonstrates Consistent Safety and Efficacy in Children with Moderate to Severe Plaque Psoriasis at 52 Weeks

ByKaitlyn Bader, Senior Editor ,Loretta Fiorillo, MD, FRCPC

April 9th 2024

Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.

Latest Updated Articles

Trending on Dermatology Times

Transformative Advances This Year and Beyond

FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol

Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control

"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions

Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population

© 2025 MJH Life Sciences^®

All rights reserved.